Early Health Technology Assessments May Help Bridge Gap Between COVID-19 Vaccine, R&D, CGD Blog Post Says

Center for Global Development: Bridging the Gap Between Need and Innovation: The Case of Vaccines
Rachel Archer, project associate at Health Intervention and Technology Assessment Program (HITAP), and colleagues discuss the potential of early health technology assessments (HTA) to systematically assess the value of vaccine candidates in the pipeline and highlight how early HTA may help bridge the gap between country demand for a COVID-19 vaccine and vaccine research and development (11/2).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.